Tech Company Financing Transactions

Amplyx Pharmaceuticals Funding Round

On 11/11/2015, Amplyx Pharmaceuticals received $49.2 million in Series B funding from RiverVest Venture Partners, 3x5 Special Opportunity Partners and BioMed Ventures.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

12730 High Bluff Dr. 160
San Diego, CA 92130
USA

Phone

(858) 345-1755

Website

www.amplyx.com

Email Address

[email protected]

Overview

Amplyx Pharmaceuticals is developing novel, broad-spectrum antifungal agents for the treatment of life-threatening fungal infections.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Michael Grey

        

Chief Executive Officer

Ciara Kennedy

        

Chief Financial Officer

Alan Fuhrman

        

Chief Medical Officer

Michael Hodges

        

VP - Bus. Development

Kevin Holme

        

VP - Operations

Paul Bien

        

VP - Operations

Pamela Wedel

        

VP - Regulatory Affairs

Elizabeth Gordon

        

Browse more venture capital transactions:

Prev: 11/11/2015: ContentOro venture capital transaction
Next: 11/11/2015: EventBoard venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to document every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary